Biocept Appoints Financial Executive Quyen Dao-Haddock to its Board of Directors

Author's Avatar
Nov 18, 2022

Biocept%2C+Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, announces the appointment of Quyen Dao-Haddock to its Board of Directors, effective immediately, increasing Board membership to eight. Ms. Dao-Haddock is a certified public accountant (CPA) with more than 20 years of financial and accounting experience. She will serve on Biocept’s Audit Committee.